EFFECT OF CANNA INDICA L. EXTRACT AGAINST CAFFEINE-NICOTINE CO-ADMINISTRATION-INDUCED EXAGGERATION IN TYPE 2 DIABETIC RATS

  • KUMBHAR SUBHASH T CRD, PRIST University, Thanjavur, TN, India &Indira College of Pharmacy, Pune, MS, India
  • UNE HEMANT D YB Chavan College of Pharmacy, Roza Baug, Harsul Road, Aurangabad. http://orcid.org/0000-0002-6854-6611
  • KANNUR DAYANAND M Indira College of Pharmacy, Pune
  • PATIL SHRINIWAS P Indira College of Pharmacy, Pune

Abstract

Objective: This study was designed to evaluate the protective effect of Canna indica L. extract against caffeine-nicotine administration-induced type 2 diabetes exaggeration in rats.

Methods: A study was conducted for three weeks in four rat groups (n=6); viz.  type 2 diabetic control group, a caffeine-nicotine diabetic control group (20mg/kg, 0.4mg/kg, ip twice daily),  and Canna indica L. extract and caffeine-nicotine treatment group and  standard drug treated caffeine-nicotine diabetic group (Glibencamide, 5mg/kg, once daily). Type 2 diabetes was induced by two weeks high fatty diet and a single dose streptozotocin (50mg/kg, ip) on 1th day of the study in all groups. Blood and urine samples were collected every week for serum biochemical analysis.

Results: Results of extract treatment and standard drug treatment were compared with untreated caffeine-nicotine co-administration group. Difference in each relevant serum parameter was analyzed through ANOVA and Dunett's t test. Extract treated caffeine-nicotine-diabetic group showed about 150-200mg/dL (p<0.001) reduction in the serum glucose than untreated caffeine-nicotine-diabetic control group. Extract treatment reduces serum glucose by 10-15 mg/dL than glibenclamide treatment with higher significance (p<0.001). Extract treatment showed better results than standard drug in liver and kidney function test and exhibited its better potential in controlling diabetic complications. Extract treatment increased HDL-C and reduced triglycerides, LDL-C, VLDL-C and TC much better and with higher significance than standard drug. Extract treatment reduced TC by at least 60-80mg/dL (p<0.01) in comparison to caffeine-nicotine-diabetic control group. Extract treatment reduced 10-15mg/dL of more total cholesterol than that of standard drug.

Conclusion: Caffeine-nicotine co-administration-induced exaggeration of type 2 diabetes was better treated by CI extract than that of standard drug gibenclamide. 

Keywords: Type 2 diabetes, Streptozotocin, Caffeine, Nicotine, Diabetic complication, Rat

Author Biographies

KUMBHAR SUBHASH T, CRD, PRIST University, Thanjavur, TN, India &Indira College of Pharmacy, Pune, MS, India

Pharmacology

UNE HEMANT D, YB Chavan College of Pharmacy, Roza Baug, Harsul Road, Aurangabad.

Pharmacology

KANNUR DAYANAND M, Indira College of Pharmacy, Pune

Pharmacognosy

PATIL SHRINIWAS P, Indira College of Pharmacy, Pune

Pharmacognosy

References

1. Abate N, Chandalia M. Ethnicity, Type 2 diabetes and migrant Asian Indians. Indian J Med Res 2007;125(3):251-8.
2. Sone H, Mizuno S, Ohashi Y, Yamada N. Type 2 diabetes prevalence in
AQ1Asian subjects. Diabetes Care 2004;27(5):1251-2.
3. Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of Type 2 diabetes: Indian scenario. Indian J Med Res 2007;125(3):217-30.
4. Gupta M. Impact of meal replacement on the health status of Type II diabetes. Int J Curr Pharm Res 2014;6(4):79-82.
5. Jorwal P, Verma R, Balhara YP. Psychological health of caregivers of individuals with Type 2 diabetes mellitus: A cross-sectional comparative study. J Soc Health Diabetes 2015;3(2):95-101.
6. Li W, Hui R. Cigarette smoking induces insulin resistance: Partly via ASP-C5L2 pathway? Biosci Hypotheses 2009;2(4):267-9.
7. Kumbhar ST, Une HD, Joshi AM, Wangikar PB. Exaggeration of Type 2 diabetes due to caffeine-nicotine co-administration: A study in rats. Int J Pharm Pharm Sci 2016;8(9):277-81.
8. Modak M, Dixit P, Londhe J, Ghaskadbi S, Devasagayam TP. Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr 2007;40(3):163-73.
9. Rahmatullah M, Mollik MA, Azam AT, Islam MR, Chowdhury MA, Jahan R, et al. Ethnobotanical survey of the Santal tribe residing in Thakurgaon District, Bangladesh. Am Eurasian J Sustain Agric 2009;3(3):889-98.
10. Purintrapiban J, Suttajit M, Forsberg NE. Differential activation of glucose transport in cultured muscle cells by polyphenolic compounds from Canna indica L. root. Biol Pharm Bull 2006;29(10):1995-8.
11. Mishra S, Yadav A, Singh SK. A review on Canna indica Linn: Pharmacognostic and pharmacological profile. J Harmon Res Pharm 2013;2(2):131-44.
12. Al-Snafi AE. Bioactive components and pharmacological effects of Canna indica - an overview. Pharm Toxicol 2015;5(2):71-5.
13. Kumbhar ST, Une HD, Patil SP, Joshi AM. Antidiabetic and hypolipidemic potential of hydroalcoholic extract of Canna indica L. root and rhizomes in rat. Eur J Pharm Med Res 2016;4(1):480-9.
14. Eddouks M, Bidi A, El Bouhali B, Hajji L, Zeggwagh NA. Antidiabetic plants improving insulin sensitivity. J Pharm Pharmacol 2014;66(9):1197-214.
15. Skovsø S. Modeling Type 2 diabetes in rats using high fat diet and streptozotocin. J Diabetes Investig 2014;5(4):349-58.
16. Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, Caggiula AR, et al. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl) 2007;190(3):269-319.
17. Kim Y, Keogh JB, Clifton PM. Polyphenols and glycemic control. Nutrients 2016;8(1). pii: E17.
18. Betteridge DJ. Diabetic dyslipidaemia. Diabetes Obes Metab 2000;2 Suppl 1:S31-6.
19. Hahn SJ, Park JH, Lee JH, Lee JK, Kim KA. Severe hypertriglyceridemia in diabetic ketoacidosis accompanied by acute pancreatitis: Case report. J Korean Med Sci 2010;25(9):1375-8.
20. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. The framingham study. JAMA 1986;256(20):2835-8.
21. Dhaliwall C, Erinmacpherson, Richardson J. Effectiveness of telephone-delivered interventions for increasing physical activity levels in persons with Type 2 diabetes or hypertension: A systematic review. J Crit Rev 2015;2(4):6-11.
22. Mbaoji FN, Ezike AC, Nworu CS, Onyeto CA, Nwabunike IA, Okoli IC, et al. Antioxidant and hepatoprotective potentials of Stemonocoleus micranthus harms (Fabaceae) stem bark extract. Int J Pharm Pharm Sci 2016;8(7):47-51.
Statistics
418 Views | 311 Downloads
Citatons
How to Cite
SUBHASH T, K., U. HEMANT D, K. DAYANAND M, and P. SHRINIWAS P. “EFFECT OF CANNA INDICA L. EXTRACT AGAINST CAFFEINE-NICOTINE CO-ADMINISTRATION-INDUCED EXAGGERATION IN TYPE 2 DIABETIC RATS”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 10, no. 4, Apr. 2017, pp. 347-51, doi:10.22159/ajpcr.2017.v10i4.16845.
Section
Original Article(s)